Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Current Liabilities (2017 - 2025)

Inspire Medical Systems' Total Current Liabilities history spans 9 years, with the latest figure at $96.1 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 8.54% year-over-year to $96.1 million; the TTM value through Dec 2025 reached $96.1 million, up 8.54%, while the annual FY2025 figure was $96.1 million, 8.54% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $96.1 million at Inspire Medical Systems, down from $110.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $110.8 million in Q3 2025 and bottomed at $19.4 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $64.6 million (2024), against an average of $62.9 million.
  • The largest annual shift saw Total Current Liabilities surged 122.26% in 2022 before it dropped 12.06% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $41.3 million in 2021, then surged by 48.13% to $61.2 million in 2022, then grew by 27.65% to $78.1 million in 2023, then grew by 13.31% to $88.5 million in 2024, then rose by 8.54% to $96.1 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Total Current Liabilities are $96.1 million (Q4 2025), $110.8 million (Q3 2025), and $93.4 million (Q2 2025).